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Summary Mitozolomide and its decomposition product MCTIC were found to be more cytotoxic to BE
colon carcinoma cells in vitro than to HT-29 cells, another colon carcinoma cell line. In addition
mitozolomide and MCTIC induced DNA interstrand crosslinks in the BE but not the HT-29 cell line. BE
cells are deficient in the repair of 06-methylguanine lesions and are designated Mer-, whereas, HT-29 cells
are proficient in this repair process and are designated Mer+. Thus DNA interstrand crosslinking produced
by mitozolomide and MCTIC appears to correlate with the Mer phenotype. Pretreatment of HT-29 cells
(Mer+) with the DNA methylating agent MNNG allows mitozolomide or MCTIC to produce DNA
interstrand crosslinks. HT-29 cells also become more sensititive to the cell killing of mitozolomide and
MCTIC with MNNG pretreatment. Pretreatment of Mer- cells (BE) had little effect on either cell killing or
DNA crosslinking levels induced by mitozolomide or MCTIC. DNA interstrand crosslinking induced by
mitozolomide and MCTIC is probably a consequence of an initial alkylation at the 06-position of guanine
followed by a delayed reaction with the opposite DNA strand.
8-carbamoyl-3-(2-chloroethyl)imidazol5, 1-dI-l, 2, 3,
5-tetrazin-4(3H)-one (mitozolomide) is a newly
synthesised heterocyclic compound which demon-
strates curative action against a wide variety of
murine tumours (Hickman et al., 1984). Chemical
studies have suggested that mitozolomide cleaves
to 5-(3-(2-chloroethyl)-triazen-1-yl)-imidazo-4-car-
boxamide (MCTIC) (Stevens et al., 1984). We
have recently shown that mitozolomide, MCTIC
and 1-(2-chloroethyl)-1-nitrosourea (CNU), react
with the DNA of L1210 cells and produce a
similar quantity of DNA interstrand crosslinks
(Gibson et al., 1984a). Both MCTIC and CNU,
and probably mitozolomide, decompose to form a
2-chloroethyldiazonium species (Stevens et al.,
1984; Shealy et al., 1975; Weinkam & Lin, 1979)
which is thought to be responsible for the initial
alkylation and subsequent crosslinking of DNA
(Kohn, 1977).
Certain human cells are known to differ in their
ability to repair adenovirus which has been
damaged by in vitro treatment with MNNG (Day
et al., 1980a). Cells which reactivate the virus and
support its replication have been designated Mer+,
and cells deficient in virus reactivation Mer- (Day
et al., 1980a). Mer+ cells were recently shown to be
more efficient at the removal of 06-methylguanine
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lesions in their DNA, whereas Mer- cells did not
repair this lesion (Day et al., 1980b). It has recently
been shown that a clear correlation exists between
the Mer phenotype and DNA interstrand
crosslinking in human cells exposed to CNU
(Erickson et al., 1980). In Mer- cells CNU
produced consistently higher levels of interstrand
crosslinking than in Mer+ cells. Little or no DNA
interstrand crosslinks were observed in the Mer+
cells after exposure to CNU. We have also shown
that a similar correlation exists between the Mer
phenotype and DNA interstrand crosslinking in
normal and SV-40 transformed human cells
exposed to either mitozolomide or MCTIC (Gibson
et al., 1984b).
Recent work has shown that pretreatment of
Mer+ cells with the methylating agent MNNG
inactivates the enzymatic activity responsible for the
removal of 06-alkylguanine lesions, and thus allows
the formation of CNU induced DNA interstrand
crosslinks (Zlotogorski & Erickson, 1983). In
addition this pretreatment was found to greatly
enhance the killing of Mer+ cells by CNU
(Zlotogorski & Erickson, 1983). Pretreatment of
Mer- cells, however, had little effect on either the
cell killing of CNU or its ability to induce a greater
quantity of DNA interstrand crosslinks
(Zlotogorski & Erickson, 1983). These data agree
with the hypothesis that CNU induced crosslinks
are produced in DNA via chloroethyl monoadduct
formation at the 06-position of guanine, followed
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by the completion of an interstrand crosslink in a
delayed reaction with the opposite DNA strand
(Kohn, 1977). The formation of such crosslinks by
the chloroethylnitrosoureas has been prevented by a
guanine-06-alkyltransferase activity purified from
an E coli cell extract (Robins et al., 1983).
Furthermore Brent has recently shown that DNA
crosslink formation, induced by the chloroethyl-
nitrosoureas, is inhibited by an extract from
cultured human leukaemic lymphoblasts (Brent,
1984). This activity which inhibits crosslink
formation copurifies with 06-methylguanine DNA
methyltransferase and shows similar kinetic
properties (Brent, 1984). Thus the same enzymatic
activity may be responsible for the removal of
methyl and chloroethyl monoadducts from the 06_
position of guanine.
In the present study we have examined the effects
of MNNG pretreatment on the mitozolomide and
MCTIC induced DNA interstrand crosslinking in
two human colon carcinoma cell lines, one
determined to be Mer+ (HT-29) and the other
Mer- (BE) (Day et al., 1980a). These studies
showed that pretreatment of HT-29 colon
carcinoma cells with MNNG prior to mitozolomide
or MCTIC exposure, conditions that should
inactivate the 06-guanine lesion repair mechanism,
allows the formation of DNA interstrand
crosslinks. This increase in DNA interstrand
crosslinking was found to correlate with a
significant increase in the cytotoxicity of
mitozolomide or MCTIC to HT-29 cells after prior
exposure to a non-toxic dose of MNNG. In
contrast, pretreatment of BE colon carcinoma cells
with MNNG had little effect on the cell killing or
DNA interstrand crosslinking levels induced by
mitozolomide or MCTIC.
Materials and methods
BE colon carcinoma cells were obtained from Dr B.
Giovanella, St Joseph's Hospital Cancer Research
Laboratory, Houston, Texas. HT-29 colon
carcinoma cells were obtained from Dr E. Jensen,
Mason Research Institute, Rockville, Md. Both cell
lines have been maintained in this laboratory for
several years. Stock cell cultures were grown at
37°C as monolayers in 75cm2 tissue culture flasks
in Eagle's minimal essential medium (MEM)
(Dutchland Laboratories, Denver, PA). The
medium was supplemented with the following
components: 10% foetal bovine serum, gentamycin
(0.05mgml-1), glutamine (0.3mgml-1), D-biotin
(0.Iugml-1), vitamin B12 (1.36pgm1-1), 0.1mM
non essential amino acids, 1 mM sodium pyruvate
and 0.02 M 4-(2-hydroxyethyl)-piperazine ethane
sulfonic acid.
For DNA alkaline elution studies, 2.5 x 10 cells
were seeded into 25cm2 flasks in 1Oml MEM and
labelled for 24h with 0.O2yuCiml-lIl4Cj thymidine
(New England Nuclear, specific activity
52mCimmol-1). The labelling period was followed
by an 18h incubation in fresh medium to allow for
the incorporation of labelled DNA into high
molecular weight DNA.
L1210 mouse leukaemia cells were grown in
suspension culture in RPMI 1630 medium
supplemented with 15% heat inactivated (60°C,
45min) foetal bovine serum. The DNA of L1210
cells was labelled by growing 3 x 105 cellsml1 for
20h in RPMI 1630 medium supplemented with
0.05,uCim-1 [3H] thymidine (New England
Nuclear, specific activity 2OCimmol-1) and 10-6 M
unlabelled thymidine.
Drug treatment
MNNG was obtained from Aldrich Chemical
Company, Milwaukee, WI. Drug was dissolved in
95% ethanol, and was stored at -20°C as 1000 x
stock at 0.001 M. Mitozolomide and MCTIC were
obtained from Professor M.F.G. Stevens,
Department of Pharmacy, University of Aston,
Birmingham, UK. Each drug was dissolved in
sterile dimethylsulfoxide immediately before
treatment of cell cultures. The concentration of
dimethylsulfoxide in either treated or control cells
was never greater than 2% v/v. MNNG was added
to cultures for 1 h at 37°C, this MNNG medium
was then removed before the addition of
mitozolomide or MCTIC for an additional 2h.
Treatments were terminated by aspiration of the
drug containing medium and replacement with
fresh MEM.
Colonyforming assays
HT-29 and BE cells were seeded at 0.1, 0.3, 1, 3,
and 10 x 103 cells per 25cm2 plastic flasks (Costar,
Cambridge, Ma). The flasks were incubated for 12-
20h to allow the cells to attach to the bottom of
the flask. The cells were then exposed to one of the
following drug protocols: control cells received no
drugs, mitozolomide or MCTIC only for 2h,
MNNG only for 1 h, MNNG for 1 h followed by a
medium change and mitozolomide or MCTIC for
an additional 2h. After 10 days of incubation in
fresh media, the flasks were rinsed with Hanks
balanced salt solution, fixed with methanol, and
then stained with a solution containing 1 ml
methylene blue, 1 ml 0.15M Na2HP04 and 1 ml
0.15 MKH2PO4 diluted to 50ml with distilled
water. Colonies were counted and the observed
plating efficiencies were 67% for HT-29 cells and
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Assay ofDNA damage by alkaline elution
The basic principles involved in the detection of
DNA damage by the alkaline elution assay have
been published and the methodology has recently
been reviewed in detail (Kohn et al., 1981). In order
to accommodate the quantity of MNNG induced
single strand breaks the modification of Zlotogorski
and Erickson (1983) was followed. Cells that were
pretreated with MNNG were only irradiated with
1.5Gy of X-ray. This was done as 2pM MNNG
was found to cause a similar quantity of DNA
strand breaks as that produced by 1.5Gy of X-ray
(data not shown). Thus MNNG pretreatment plus
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1.5Gy X-ray exposure achieved the same effect as
3.0Gy X-ray exposure to cells that were not
pretreated with MNNG.
Results
Assays of the cytotoxicity of mitozolomide (left
panel) and MCTIC (right panel) to HT-29 and BE
colon carcinoma cells are shown in Figure 1. These
results are in agreement with the Mer status of the
cells, BE (Mer-) are more sensitive to both
mitozolomide and MCTIC. When the cells are
b
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Figure 1 Survival of colony forming ability of BE (0) and HT-29 (U) colon carcinoma cells exposed to
various concentrations of mitozolomide (a) and MCTIC (b) for 2h at 37°C. Pretreatment of BE (0) and HT-
29 (E1) with 21M MNNG for 1 h followed by either mitozolomide (a) or MCTIC (b) for 2h at 37°C are
shown. The data of MNNG plus either mitozolomide or MCTIC treatment have been normalised against the
survival of cells exposed to MNNG alone. Points and error bars represent the mean ±s.d. of 9 or more
replicate plates in three separate experiments.254 N.W. GIBSON & L.C. ERICKSON
pretreated with 2pM MNNG we find an interesting
difference between the cell lines. Following MNNG
pretreatment there is a moderate increase in BE cell
killing, however, in HT-29 cells after MNNG
pretreatment we find a large increase in the cell
killing relative to either mitozolomide or MCTIC
alone. These results are in agreement with those
previously published for the chloroethylnitrosourea
CNU (Zlotogorski & Erickson, 1983).
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The appearance of DNA-DNA interstrand
crosslinks was examined in both BE (upper panels)
and HT-29 (lower panels) treated with
mitozolomide (Figure 2) or MCTIC (Figure 3). In
addition the effect of MNNG pretreatment on the
ability of either mitozolomide or MCTIC to induce
DNA-DNA interstrand crosslinking was determined
(Figures 2 and 3, right hand side panels). Both
mitozolomide and MCTIC induced DNA
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F-gre 2 Alkaline elution assays to test for the formation of DNA interstrand crosslinks after mitozolomide
treatment on BE (a) with HT-29 (b) colon carcinoma cell Cells were treated with various drug concentrations
as indicated for 2h at 37CC and then allowed to incubate for 6h in drug free medium, conditions which are
sufficient to allow the formation of DNA interstrand cslinks (Gibson et aL, 1984b). The effect of
pretreatment of BE (c) and HT-29 (d) cells with 2uM MNNG for lbh foilowed by mitozolomide for 2h is
shown. Prior to alkaline elution, cells were irradiated with 3.OGy yirradiation from a 137CS source; cls
pretreated with MNNG were exposed to 1.5Gy y-irradiation; [3H] L1210 inten standard ces received
3.OGy. These profiles are taken from one experimet and are reprsentatie of at least two other independent
experiments.
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Figure 3 Alkaline elution assays to test for the formation of DNA interstrand crosslinks after MCTIC
treatment on BE (a) and HT-29 (b) colon carcinoma cells. The effect of pretreatment of BE (c) and HT-29 (d)
with 2liM MNNG followed by MCTIC on the formation of DNA interstrand crosslinking is seen. Drug
treatments are as indicated. These profiles are taken from one experiment and are representative of at least
two other independent experiments.
interstrand crosslinking in the BE colon carcinoma
cell line. Similar levels of DNA interstrand
crosslinking were observed either with or without
MNNG pretreatment in the BE cell line (Figures 2
and 3, upper panels). In the HT-29 colon
carcinoma cell line neither mitozolomide nor
MCTIC induced DNA interstrand crosslinking
(Figures 2 and 3, left hand bottom panel).
However, pretreatment of HT-29 cells with MNNG
was found to allow the formation of mitozolomide
or MCTIC induced crosslinks where previously
they had been undetected. Furthermore the
significance of MNNG pretreatment on the DNA
crosslinking levels produced by mitozolomide and
MCTIC in HT-29 cells can be seen from Table I.
This table presents the mean +s.d. of four
independent experiments. In addition this table
shows the inability of MNNG pretreatment to alter
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Table I DNA interstrand crosslinking (RAD equivalents) in Be and HT-29 colon carcinoma cells treated with
mitozolomide or MCTIC with or without MNNG pretreatment.
Concentration No MNNG pretreatment MNNG pretreatment
Cell line Drug PM Mean+s.d. Mean+s.d.
12.5 4.8+1.6 8.8+ 7.3
Mitozolomide 25 12.3+4.8 14.8+ 7.6
50 25.0+6.4 22.5+10.7
BE
12.5 5.2+2.3 6.1+ 5.7
MCTIC 25 11.3+5.0 10.8+ 9.6
50 24.5+9.9 24.5+ 10.2
100 -3.7±2.8 27.2+ 9.8
Mitozolomide 200 -8.8+5.9 57.6+20.7
300 -6.2+4.0 72.0+28.6
HT-29
100 -12.4+5.3 27.3+ 15.5
MCTIC 200 -10.2+3.6 51.2+12.6
300 - 14.2+2.3 82.3+25.0
the DNA interstrand crosslinking levels produced
in BE cells by mitozolomide and MCTIC.
One possible explanation for the differential in
both cytotoxicity and DNA interstrand crosslinking
between the BE and HT-29 colon carcinomas
would be that drug uptake is different in the two
cell lines. Figure 4 shows the quantity of DNA-
protein crosslinks induced by mitozolomide in both
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BE and HT-29 cell lines. Mitozolomide at
equimolar concentrations appears to induce similar
quantities of DNA-protein crosslinks in both cell
lines. In addition pretreatment of either cell line
with MNNG does not alter the quantity of DNA-
protein crosslinks formed after exposure to
mitozolomide (data not shown). Thus drug uptake
and intracellular reactivity would appear to be
b
Elution time (h)
Figure 4 Alkaline elution assays to test for the formation of DNA-protein crosslinks after mitozolomide
treatment on BE (a) and HT-29 (b) colon carcinoma cells. Cells were treated with drug concentrations as
indicated for 2h at 37°C and then allowed to incubate for 6h in drug free medium. Prior to alkaline elution
all cells were irradiated with 30Gy of y-irradiation from a "37Cs source. These profiles are taken from
one experiment and are representative of at least two other independent experiments. (0) 30.0Gy; (A)
12.5jm+30Gy; (U) 25pM+3OGy; (*) 50uM+30Gy; (O) l00pM+3OGy; (V) 200iM+3OGy; (O)
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similar in both cell lines. This is in good agreement
with data previously obtained for CNU
(Zlotogorski & Erickson, 1984).
Discussion
We have previously shown that mitozolomide and
its decomposition product MCTIC were able to
induce DNA interstrand crosslinks in an SV-40
transformed human embryonic cell line which was
deficient (Mer-) in the ability to repair 06_
alkylguanine lesions (Gibson et al., 1984b). We also
showed that in a normal human embryonic cell line
(Mer+) proficient in the repair of 06-alkylguanine
lesions no DNA interstrand crosslinking was
induced by mitozolomide and MCTIC (Gibson et
al., 1984b). From these data we hypothesised that
mitozolomide may chloroethylate DNA, in
particular at the 06 position of guanine which then
results in a DNA crosslink by a similar mechanism
to that previously proposed for the chloroethyl-
nitrosoureas (Kohn, 1977).
In this study with mitozolomide a similar series
of findings has been presented. Namely that Mer-
cells (BE) are more sensitive to mitozolomide and
MCTIC than Mer+ cells (HT-29), and that a
correlation between cytotoxicity and DNA
interstrand crosslinking appears to exist for the BE
colon carcinoma. In the Mer+ cell line, HT-29,
mitozolomide was both less cytotoxic and formed
negligible DNA interstrand crosslinks.
Furthermore we have shown that the DNA
methylating agent MNNG is capable of inhibiting
the process by which HT-29 cells are able to avoid
the formation of DNA interstrand crosslinks
induced by mitozolomide or its decomposition
product MCTIC. In contrast, pretreatment of BE
cells with MNNG had little effect on the quantity
of DNA interstrand crosslinks induced by
mitozolomide or MCTIC. In addition the increase
in DNA crosslinking induced in HT-29 cells by
mitozolomide and MCTIC with MNNG
pretreatment correlates well with the enhanced
sensitivity of these cells after exposure to the same
drug protocol.
The differences observed between the HT-29 and
BE cells, and between HT-29 cells with or without
MNNG pretreatment, may be a consequence of
impaired drug uptake. However, the similarity
between the DNA-protein crosslinking levels
observed in HT-29 and BE cells at equimolar
concentrations suggests that intracellular drug
reactivity is equivalent. Furthermore no difference
in the DNA-protein crosslinking induced by
mitozolomide was found with or without MNNG
pretreatment (data not shown). These results are in
good agreement with those obtained by Zlotogorski
and Erickson(1984) with the chloroethylnitrosourea
CNU.
Two mechanisms by which MNNG may
inactivate the repair of 06-alkylguanine lesions
have been proposed (Zlotogorski & Erickson, 1983;
1984): MNNG may react directly with the repair
protein thus inactivating it, or MNNG may directly
alkylate the DNA, and then the protein which
reacts with the alkylated guanine in a stoichiometric
fashion is simply depleted. The evidence for and
against both these mechanisms has been discussed
in detail elsewhere (Zlotogorski & Erickson, 1983;
1984) and will not be elaborated upon here.
Chemical studies have shown that mitozolomide
cleaves under physiological conditions to produce
the monochloroethyltriazene MCTIC (Stevens et
al., 1984). Thus the ability of MCTIC to mimic the
results of mitozolomide in this and numerous other
studies (Gibson et al., 1984a, b; Horgan et al.,
1983), strongly suggests that this decomposition
pathway is important for the pharmacological
expression of mitozolomide. In this study we have
shown that Mer+ cells which are proficient in the
repair of 06-methylguanine lesions do not allow the
formation of DNA interstrand crosslinking by
chloroethylating agents such as mitozolomide.
Pretreatment of these cells with MNNG, conditions
which inhibit the 06-methylguanine transferase
activity, allows the formation of mitozolomide
induced DNA interstrand crosslinking in Mer+
cells. The results presented here strengthen our
hypothesis that mitozolomide induced crosslinks
probably arise after an initial alkylation at the 06_
position of guanine residues in DNA. In addition
the enzymatic activity responsible for repairing 06_
methylguanine adducts in DNA would also appear
to repair 06-chloroethylguanine adducts.
In conclusion the presence of a DNA repair
system capable of repairing lesions at the 06_
position of guanine may make tumour cells
resistant to treatment with mitozolomide or
MCTIC. However, pretreatment with agents that
methylate the 06-position of guanine, conditions
which can inhibit this repair activity, may be used
to sensitize tumour cells resistant to treatment with
mitozolomide or MCTIC. The high carcinogenic
potential of MNNG exposure suggests that this
protocol will have limited applicability in vivo.
However, recent experiments with the clinically
used DNA methylating agent, streptozotocin,
suggests that pretreatment with streptozotocin to
sensitise human tumours to chloroethylating agents
may have in vivo applicability (Erickson and
Barnes; Gibson, Barnes and Erickson, in
preparation).
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